Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Retinyl acetate is a synthetic acetate ester of retinol (vitamin A alcohol) and a lipid-soluble *provitamin A* compound used as a dietary supplement or food additive to fortify foods with vitamin A[4][2][3]. After ingestion, retinyl acetate is hydrolyzed in the intestine to release retinol, which is then absorbed and converted in the body to retinal (necessary for vision), and retinoic acid (which acts as a ligand for retinoic acid receptors, regulating gene transcription critical for cell differentiation, immune function, and epithelial maintenance)[1][4]. Used primarily for vitamin A supplementation or to treat/prevent vitamin A deficiency, it has good stability compared to retinol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on retinyl acetate.